The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making and selling the drug, pravastatin, a generic version of the brand-name medicine Pravachol.

Another generic drug maker, Glenmark Pharmaceuticals, agreed to pay a $30 million criminal penalty and to divest its pravastatin business as well.

  • @ALilOff
    link
    91 year ago

    Completely spaced about the Teva pharmaceuticals, was wondering what Teva Sandals were doing making drugs.

    • @DoomBot5
      link
      11 year ago

      The word just translates to “nature” in Hebrew. Generic enough word to be used by multiple businesses.